A Study on Spiramycine in Acute Tonsillitis and Sinusitis
Article Sidebar
Main Article Content
Abstract
the objective of the study was to assess the efficacy and tolerance of Rovamycine forte (spramycine) in cases of acute Tonsillitis and sinusitis. It was a prospective non comparative, open ended, cliical trial, in 60 patients, at the out patient department of LRH, Peshawar. it was conducted during November 1994 to march 1995. The results showed overall efficacy of the drug to be 90% and excellent to good tolerance as 91%, for both indications. Thus, rovamycine Forte (Spiramycine) proved to be an excellent macrolide, to be recommended in common upper Respiratory tract Infections (URTI) e.g. Acute Tonsillitis and sinusitis. its short therapy, has an added advantage in terms of compliance.
Article Details
How to Cite
1.
Ullah M. A Study on Spiramycine in Acute Tonsillitis and Sinusitis. J Postgrad Med Inst [Internet]. 2011 Aug. 28 [cited 2024 Dec. 26];9(2). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/503
Issue
Section
Original Article
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.